These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 20376044)

  • 21. Prospective assessment of changing from placebo to IFN beta-1a in relapsing MS: the PRISMS study.
    Oger J; Francis G; Chang P;
    J Neurol Sci; 2005 Oct; 237(1-2):45-52. PubMed ID: 16026803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination therapy for treatment of multiple sclerosis.
    Lublin FD; Reingold SC
    Ann Neurol; 1998 Jul; 44(1):7-9. PubMed ID: 9667587
    [No Abstract]   [Full Text] [Related]  

  • 23. Interferon beta-1A: new preparation. A short-term impact on the course of multiple sclerosis.
    Prescrire Int; 1998 Oct; 7(37):142-3. PubMed ID: 10915418
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Advances in the therapy of multiple sclerosis with interferon beta-1a].
    Nervenarzt; 1997 Oct; 68(10 Suppl):1-8. PubMed ID: 9375645
    [No Abstract]   [Full Text] [Related]  

  • 25. Targets for the therapeutic action of interferon-beta in multiple sclerosis.
    Hartung HP; Kieseier BC
    Ann Neurol; 1996 Dec; 40(6):825-6. PubMed ID: 9007085
    [No Abstract]   [Full Text] [Related]  

  • 26. The use of interferon beta at the time of initial diagnosis of multiple sclerosis.
    Pender MP
    J Clin Neurosci; 2001 Jul; 8(4):381-2. PubMed ID: 11437589
    [No Abstract]   [Full Text] [Related]  

  • 27. [Interferon beta-1b in multiple sclerosis. Basic therapy in intermittent and secondary progressive course].
    Nervenarzt; 1999 Nov; 70(11 Suppl Basisthera):1-4. PubMed ID: 10603601
    [No Abstract]   [Full Text] [Related]  

  • 28. Should all patients with an initial diagnosis of multiple sclerosis be treated with beta interferon?
    Hodgkinson SJ
    J Clin Neurosci; 2001 Jul; 8(4):378-9. PubMed ID: 11437587
    [No Abstract]   [Full Text] [Related]  

  • 29. Should all patients with an initial diagnosis of multiple sclerosis be treated with beta interferon? The case against.
    Macdonell R
    J Clin Neurosci; 2001 Jul; 8(4):379-81. PubMed ID: 11437588
    [No Abstract]   [Full Text] [Related]  

  • 30. [Immunomodulatory treatments for multiple sclerosis: lessons from direct comparative studies].
    Ouallet JC
    Rev Neurol (Paris); 2010 Jan; 166(1):21-31. PubMed ID: 19596382
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of interferon-beta treatment on the blood-brain barrier.
    Kraus J; Oschmann P
    Drug Discov Today; 2006 Aug; 11(15-16):755-62. PubMed ID: 16846804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interferon beta induces interleukin-10 expression: relevance to multiple sclerosis.
    Rudick RA; Ransohoff RM; Peppler R; VanderBrug Medendorp S; Lehmann P; Alam J
    Ann Neurol; 1996 Oct; 40(4):618-27. PubMed ID: 8871582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pearls and pitfalls of interferon beta treatment for multiple sclerosis.
    Corona T; León C; Ruiz JL
    Neurologia; 1999 Nov; 14(9):467-8. PubMed ID: 10613023
    [No Abstract]   [Full Text] [Related]  

  • 34. Panniculitis after subcutaneous injection of interferon beta in a multiple sclerosis patient.
    Heinzerling L; Dummer R; Burg G; Schmid-Grendelmeier P
    Eur J Dermatol; 2002; 12(2):194-7. PubMed ID: 11872423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interferon-beta treatment in patients with childhood-onset multiple sclerosis.
    Mikaeloff Y; Moreau T; Debouverie M; Pelletier J; Lebrun C; Gout O; Pedespan JM; Van Hulle C; Vermersch P; Ponsot G
    J Pediatr; 2001 Sep; 139(3):443-6. PubMed ID: 11562627
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Should neutralizing antibodies be monitored during interferon-beta treatment for multiple sclerosis?
    Oger J; Gibbs E
    Nat Clin Pract Neurol; 2006 Feb; 2(2):76-7. PubMed ID: 16932528
    [No Abstract]   [Full Text] [Related]  

  • 37. [Long-term interferon therapy. Effectiveness in multiple sclerosis continues].
    MMW Fortschr Med; 2002 May; Suppl 2():84. PubMed ID: 12070862
    [No Abstract]   [Full Text] [Related]  

  • 38. [New trends, clinical questions and long-term experiences. Therapy of multiple sclerosis with interferon beta-1b].
    Nervenarzt; 1998 Nov; 69(11 Suppl Therapie D):1-8. PubMed ID: 9845885
    [No Abstract]   [Full Text] [Related]  

  • 39. [Interferon in multiple sclerosis. The earlier, the better?].
    MMW Fortschr Med; 2001 May; 143 Suppl 2():94. PubMed ID: 11434275
    [No Abstract]   [Full Text] [Related]  

  • 40. Immunotherapy for multiple sclerosis: the curious case of interferon beta.
    Stüve O; Ransohoff RM
    Arch Neurol; 2009 Oct; 66(10):1193-4. PubMed ID: 19822773
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.